title: Effect of hepatocyte growth factor on early human haemopoietic cell development.
abstract: Hepatocyte growth factor (HGF) stimulates cell proliferation, differentiation and migration by binding to its receptor, MET R. Whether the HGF/MET R axis plays an important regulatory role in human haemopoietic cell growth is an unresolved issue. To investigate this situation, we employed several complementary strategies including RT-PCR, FACS analysis, and mRNA perturbation with oligodeoxynucleotides (ODN). We found that very primitive, FACS sorted, CD34+ Kit+ marrow mononuclear cells (MNC) failed to express RT-PCR detectable MET R mRNA. In contrast, MET R expression was easily detectable by RT-PCR in marrow stroma fibroblasts, in cells isolated from BFU-E and CFU-GM colonies, and in unselected normal MNC. Subsequent FACS analysis revealed that MET R protein was detectable on approximately 5% of the latter cells. HGF, at concentrations of 1-50 ng/ml, had no demonstrable effect on survival or cloning efficiency of normal CD34+ MNC in serum-free cultures. Antisense ODN mediated perturbation of MET R mRNA expression in normal CD34+ MNC, with FACS documented decline in protein expression, had no effect on the ability of these cells to give rise to haemopoietic colonies of any lineage. We also examined the biology of HGF/MET R expression in malignant haemopoietic cells. Using the strategies described above, we found that MET R mRNA was expressed in many human haemopoietic cell lines, and that the protein was expressed at high levels on HTLV transformed T lymphocytes. Wild-type CML and AML blast cells also expressed MET mRNA, and HGF was able to co-stimulate CFU-GM colony formation in approximately 20% of cases studied. Therefore, although the HGF/MET R axis appears to be dispensable for normal haemopoietic cell growth, it may play a role in the growth of malignant haemopoietic progenitor cells.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, U.S.A.
authors.forename: M Z
authors.initials: MZ
authors.lastname: Ratajczak
authors.forename: W
authors.initials: W
authors.lastname: Marlicz
authors.forename: J
authors.initials: J
authors.lastname: Ratajczak
authors.forename: M
authors.initials: M
authors.lastname: Wasik
authors.forename: B
authors.initials: B
authors.lastname: Machalinski
authors.forename: A
authors.initials: A
authors.lastname: Carter
authors.forename: A M
authors.initials: AM
authors.lastname: Gewirtz
mesh_terms: D002460:Cell Line; D002470:Cell Survival; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects*; D017228:Hepatocyte Growth Factor / Q000494:pharmacology*; D006801:Humans; D009841:Oligonucleotides / Q000378:metabolism; D016133:Polymerase Chain Reaction; D019859:Proto-Oncogene Proteins c-met / Q000502:physiology; D012333:RNA, Messenger / Q000378:metabolism
chemical_list: D009841:Oligonucleotides; D012333:RNA, Messenger; D017228:Hepatocyte Growth Factor; D019859:Proto-Oncogene Proteins c-met